License Exception MED, published by the US Department of Commerce’s Bureau of Industry and Security (BIS) on April 25, authorizes the export, reexport, or in-country transfer of EAR99 “medical devices” to non-military hospitals but comes with new restrictions and due diligence requirements.
Since Russia’s further invasion of Ukraine began on February 24, 2022, BIS has steadily expanded export controls to include license requirements for nearly all medical devices (think everything from X-ray machines and sophisticated equipment to catheters and needles). In the meantime, the Crimea, Donetsk, and Luhansk regions of Ukraine — currently under Russian occupation — are subject to a near-total embargo as well as comprehensive economic sanctions. Die And Stamping
![Bureau of Industry and Security Publishes License Exception MED](http://img4.grofrom.com/uploads/wp-content/uploads/2020/07/CHECKING-GAUGES.jpg)
Starting on April 29, medical device exporters will be able to take advantage of License Exception MED under § 740.23 of the Export Administration Regulations (EAR).
Only “medical devices” which are EAR99 (i.e. not described on the Commerce Control List (CCL))[1] and EAR99 parts, components, accessories or attachments, thereof. BIS defines “medical devices” using the definition of “device” under Sec. 201 of the US Food, Drug, and Cosmetic Act:
“[A]n instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is—
Russia, Belarus, and the Crimea, Donetsk, and Luhansk regions of Ukraine.
Replacement parts for medical devices are covered by MED only if:
MED only lets exporters off the hook from license requirements under EAR Sections 746.5 (Russia/Belarus industry sector sanctions), 746.6 (embargo on Crimea, Donetsk, and Luhansk), or 746.10 (luxury goods sanctions on Russia/Belarus) of the EAR. It does NOT apply to:
Additionally, parties relying on MED must “maintain a system of distribution that ensures that [items exported, reexported, or transferred] are not delivered to proscribed persons or to any entities engaged in any type of production.” BIS provides several examples of acceptable verification procedures: obtaining affirmations or other documentation from a consignee, or periodic on-site spot-checks (e.g., by the exporter, an auditing firm, or a recognized nongovernmental organization [NGO]). BIS officials have verbally confirmed that the agency deliberately included options other than on-site verification, given the risks and impracticalities nowadays of snooping around Russia to do checks on US export compliance.
Verification records must be maintained for five years and provided to BIS upon request.
License exception MED provides much-needed relief for US medical suppliers who have had to contend with the BIS’s license requirements, follow-up questions, and at-time lengthy approval process over the last couple years. However, any business which deals with Russia (or with Belarus, not to mention the comprehensively embargoed and sanctioned Ukrainian regions of Crimea, Donetsk, and Luhansk) should not let down their guard. It remains as important as ever to screen customers and counterparties, verify end use, and keep good records. Contact your export compliance counsel if you have any questions or concerns.
[1] Due to the EAR’s Statement of Understanding on “medical equipment,” commodities incorporating items on the CCL not controlled for frightening reasons (nuclear/chemical/biological weapons or missiles) that are specially designed for medical end-use, are classified as EAR99.
Post Your Public Notice Today!
You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.
Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is www.NatLawReview.com intended to be a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional. NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us.
Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.
The National Law Review - National Law Forum LLC 2020 Green Bay Rd., Suite 178, Highland Park, IL 60035 Telephone (708) 357-3317 or toll free (877) 357-3317. If you would ike to contact us via email please click here.
Die Metal Stamping Copyright ©2024 National Law Forum, LLC